Nexpoint Asset Management’s CERo Therapeutics Warrants CEROW Stock Holding History

Nexpoint Asset Management’s Portfolio CEROW Stock Details CEROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-108,741	Closed	-$1.45K	–	131
2025 Q3	$1.45K	Hold	108,741	–	–	﹤0.01%	98
2025 Q2	$2.59K	Hold	108,741	–	–	﹤0.01%	86
2025 Q1	$1.58K	Hold	108,741	–	–	﹤0.01%	83
2024 Q4	$903	Hold	108,741	–	–	﹤0.01%	92
2024 Q3	$555	Hold	108,741	–	–	﹤0.01%	90
2024 Q2	$2.19K	Hold	108,741	–	–	﹤0.01%	85
2024 Q1	$7.42K	Hold	108,741	–	–	﹤0.01%	83
2023 Q4	$2.56K	Hold	108,741	–	–	﹤0.01%	68
2023 Q3	$7.79K	Hold	108,741	–	–	﹤0.01%	81
2023 Q2	$6.64K	Hold	108,741	–	–	﹤0.01%	98
2023 Q1	$4.36K	Hold	108,741	–	–	﹤0.01%	98
2022 Q4	$4.69K	Hold	108,741	–	–	﹤0.01%	118
2022 Q3	$9K	Hold	108,741	–	–	﹤0.01%	136
2022 Q2	$11K	Hold	108,741	–	–	﹤0.01%	139
2022 Q1	$24K	Hold	108,741	–	–	﹤0.01%	154
2021 Q4	$46K	Buy	+108,741	New	+$50.1K	0.01%	209

Other funds holding CEROW

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Nexpoint Asset Management's CEROW Position: Q4 2025 in Review

Nexpoint Asset Management sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 108,741 shares — an estimated $1.45K sold.

Nexpoint Asset Management first reported a position in CEROW in Q4 2021 and held it in 16 quarters. The position peaked at $46K in Q4 2021. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.

Nexpoint Asset Management reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
Nexpoint Asset Management sold 108,741 CERo Therapeutics Warrants shares in Q4 2025, an estimated $1.45K.
Nexpoint Asset Management first reported a position in CERo Therapeutics Warrants in Q4 2021 and held it in 16 quarters.
Nexpoint Asset Management's CERo Therapeutics Warrants position peaked at $46K in Q4 2021.
1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.

Based on Nexpoint Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.